title: Bladder tuberculosis after BCG therapy.
abstract: The initial treatment of bladder cancer is transurethral resection (TUR), but this cancer recurs at an important rate, and has 14% chance of progression after TUR alone. Intravesical chemotherapy with Bacillus Calmette-Guerin (BCG) is effective against recurrence and progression of bladder cancer. However, this therapeutic expose to many local and systemic side-effects. We report a case of 63-year-old man who presented bladder tuberculosis after a BCG therapy, which required 6 months of antitubercular therapy.
authors: Department of Nephrology, Constantine Military Hospital, Algeria. ihab_bouhbel@yahoo.fr
authors: A
authors: A
authors: Bouhabel
authors: F
authors: F
authors: Takoucht
authors: W
authors: W
authors: Bousbia
authors: B
authors: B
authors: Hamada
authors: N
authors: N
authors: Lemaiaci
mesh_terms: D000283:Administration, Intravesical; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome; D014376:Tuberculosis / Q000276:immunology*; D001745:Urinary Bladder Diseases / Q000276:immunology* / Q000382:microbiology*
chemical_list: D001500:BCG Vaccine